UCLA Health
At UCLA Health, we provide the best health care, using the latest medical technology — healing humankind one patient at a time.
- 2024 Heart Failure Symposium
- 17th Annual UCLA Liver Diseases Symposium
- 12th Annual UCLA-Mellinkoff GI and Hepatology Symposium
- Personalized Nutrition in Primary Care 2024
- 2023 Heart Failure Symposium
- 2023 UCLA ECMO and Life Support Symposium
- 11th Annual UCLA-Mellinkoff GI and Hepatology Symposium
- 15th Annual UCLA Liver Diseases Symposium
- Neurosurgery
- Nephrology
- Cardiovascular
- Oncology
- Liver Grand Rounds
- Liver Hour
- Gastroenterology
- Advanced Lung Disease and Lung Transplantation Symposium 2023
- 16th Annual UCLA Liver Diseases Symposium
- Personalized Nutrition 2022
- 2024 Advanced Lung Disease and Lung Transplantation Symposium
- Events
Playback speed
10 seconds
ASCO GI 2023 Phase 3 STELLAR-303 Study: XL092 in Combination With Atezolizumab vs. Regorafenib in Patients With Previously Treated mCRC
By
ASCO GI 2023 Conference Coverage
FEATURING
J. Randolph Hecht
By
ASCO GI 2023 Conference Coverage
FEATURING
J. Randolph Hecht
391 views
January 25, 2023
Comments 0
Login to view comments.
Click here to Login